Sanne de Bruin

121 InPUT- pilot study in the Netherlands 16. Tinmouth A, Thompson T, Arnold DM, et al. Utilization of frozen plasma in Ontario: A provincewide audit reveals a high rate of inappropriate transfusions. Transfusion . 2013;53(10):2222-2229. doi:10.1111/ trf.12231 17. Dara SI, Rana R, Afessa B, Moore SB, Gajic O. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med . 2005;33(11):2667-2671. doi:10.1097/01. CCM.0000186745.53059.F0 18. Qiang, J., Thompson, T., Callum, J., Pinkerton, P. H., & Lin Y. Variations in Red Blood Cell and Frozen Plasma Transfusion Rates Across 60 Ontario Community Hospitals. Blood . 2017;130(Suppl 1):4935. http://www.bloodjournal.org/content/130/Suppl_1/4935. 19. Baharoglu MI, Cordonnier C, Salman RAS, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet . 2016;387(10038):2605-2613. doi:10.1016/S0140- 6736(16)30392-0 20. Curley A, Stanworth SJ, Willoughby K, et al. Randomized Trial of Platelet-Transfusion Thresholds in Neonates. N Engl J Med . 2019;380(3):242-251. doi:10.1056/NEJMoa1807320 21. Walsh TS, Stanworth SJ, Prescott RJ, et al. Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med . 2010;38(10):1939-1946. doi:10.1097/CCM.0b013e3181eb9d2b 22. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane database Syst Rev . 2011;(3):CD001886. doi:10.1002/14651858.CD001886. pub4 23. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (London, England) . 2010;376(9734):23-32. doi:10.1016/ S0140-6736(10)60835-5 4